Tag Archives: Patients

FDA Approves Bronchitol (mannitol) Inhalation Powder to Improve Pulmonary Function in Adult Patients with Cystic Fibrosis

FDA Approves Bronchitol (mannitol) Inhalation Powder to Improve Pulmonary Function in Adult Patients with Cystic Fibrosis CARY, N.C., Nov. 02, 2020 (GLOBE NEWSWIRE) — Chiesi USA, Inc., the U.S. affiliate of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), received U.S. Food and Drug Administration (FDA) approval of Bronchitol (mannitol) inhalation powder. Bronchitol… Read More »

Indian diet for heart patients

Want to have a quick and light meal? Antioxidants, which are found in brightly coloured fruits, vegetables and grains help to control the amount of free radicals in the body. Please note that the portion or serving size will vary depending on the age, size, health of the patient and any other factors that the… Read More »

Half of Medicare patients do not receive recommended healthcare after hospitalization

In the period from October 2015 to September 2016, before the Affordable Care Act, a substantial portion of Medicare patients referred to home healthcare after hospitalization did not receive that care, new findings show. Using national data, the researchers detailed how often Medicare patients referred to home healthcare services after a hospital discharge received one… Read More »

From cancer and Covid to dementia, BAME patients are shamefully more at risk

Britain’s health divide: From cancer and Covid to dementia and childbirth, black and ethnic minority patients are shamefully more at risk. And worst of all? We STILL don’t know why By Lois Rogers and Libby Galvin for the Daily Mail Published: 22:00 BST, 24 August 2020 | Updated: 08:02 BST, 25 August 2020 Moise Roche… Read More »

FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis

FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis Print this page Basel, August 20, 2020 — Novartis today announced that the US Food and Drug Administration (FDA) has approved Kesimpta® (ofatumumab, formerly OMB157) as an injection for subcutaneous use for the treatment of relapsing forms of multiple sclerosis (RMS), to include clinically… Read More »

Diet for blood clot patients

People taking the blood thinning medication warfarin may need to moderate vitamin K levels in their diets. Vitamin K may interfere with the effectiveness of warfarin. A doctor may prescribe warfarin to someone who has had a blood clot in the past, as they are at a higher risk of blood clots in the future.… Read More »